# Semaglutide and Gastric Bypass Delay Weight Loss Plateau: Study Finds ### Key Points: – A recent study conducted by Scripps Research has shown that combining semaglutide (a medication used for weight loss) with gastric bypass surgery can delay the point at which weight loss plateaus. – The study followed 100 participants who had undergone gastric bypass surgery and were given either semaglutide or a placebo for 52 weeks. – Participants who received semaglutide continued to lose weight beyond the plateau typically seen after surgery, with an average weight loss of 26.7% after one year. – These findings suggest that combining semaglutide with gastric bypass surgery could be a promising approach for individuals struggling with weight loss plateaus. In conclusion, the study conducted by Scripps Research indicates that combining semaglutide with gastric bypass surgery may offer a valuable strategy to prevent weight loss plateaus and achieve significant weight reduction in individuals. This research provides hope for those seeking effective ways to manage their weight and improve their overall health and well-being. If you are interested in exploring weight loss options, consider contacting Mindful Evolution for guidance and support through telehealth services available in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Weight Loss Disclaimer: Individual results may vary. It’s essential to consult with a healthcare provider before starting any weight loss program or making significant changes to your diet or exercise routine.